Phase 2 NSCLC Stage III Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
NSCLC Stage IVNSCLC Stage III
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer30 enrolled20 locationsNCT06552234
Recruiting
Phase 2
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer
NSCLC Stage IINSCLC Stage III
Shanghai Pulmonary Hospital, Shanghai, China54 enrolled1 locationNCT07410975
Recruiting
Phase 2
Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
NSCLC Stage IVNSCLC Stage IIIB
Goethe University50 enrolled16 locationsNCT05281406
Recruiting
Phase 2
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC
NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB
University Hospital Heidelberg20 enrolled1 locationNCT04865250
Recruiting
Phase 2
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
OncologyNSCLC Stage IVNSCLC Stage III
Vestre Viken Hospital Trust138 enrolled1 locationNCT05344209